iNK cell therapy for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new type of immune cell therapy called iNK (natural killer cells) for people with solid tumors that have come back or spread. It aims to see if the treatment is safe and can help shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid cancer that has returned or spread and cannot be completely removed by surgery or radiation.
- Standard treatments (like chemotherapy) have failed, caused severe side effects, or are not available for your cancer.
- You have at least one tumor that can be measured on a scan (like a CT or MRI).
- Your liver, kidneys, and blood cell counts are in good enough shape (your doctor will check).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a special immune cell called iNK cells after standard chemoradiation can help keep small cell lung cancer from coming back.
This trial tests an investigational natural killer (NK) cell therapy for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if these immune cells can shrink tumors and are safe.
This trial tests whether adding special immune cells (iNKT cells and CD8+ T cells) given by IV infusion can help treat advanced cancers. It mainly looks at safety first, and also checks whether the treatment can shrink or control cancer.
This trial tests an injection of your own immune cells (tumor-infiltrating lymphocytes) to see if they can fight advanced solid tumors like stomach or lung cancer. Doctors will remove one of your tumors, grow the immune cells from it, and then give them back to you.
This trial tests a new type of immune cell therapy (SK-NK injection) for people with advanced solid tumors that have stopped responding to at least two prior treatments and have developed malignant ascites (fluid buildup in the belly from cancer). The goal is to see if this treatment can help control the cancer and reduce the need for draining the fluid.
This study tests a new immune cell treatment called EB-NK-301, which are lab-modified natural killer cells designed to attack cancer cells that have a protein called TROP2. The trial is for people with advanced solid tumors (cancers that have spread) whose cancer has stopped responding to standard treatments.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.